Soteria Biotherapeutics is Drug Discovery in United States that focus on T-LITETM platform business. Founded in 2018. They cover business area such as developer, next generation, switchable bispecific t-cell engager, cancer patient, solid tumor, small molecule-dependent activation, bispecific antibody therapy, safe and more efficacious treatment, pulsatile activity, reduce side effect, high dosing.
2018
( 6 years old in 2024 )
T-LITETM Platform
-
953 Indiana Street
San Francisco, CA 94107
United States
Private
developernext generationswitchable bispecific t-cell engagercancer patientsolid tumorsmall molecule-dependent activationbispecific antibody therapysafe and more efficacious treatmentpulsatile activityreduce side effecthigh dosing
* We use standard office opening hours in near Soteria Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Soteria Biotherapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Soteria Biotherapeutics business is focusing on T-LITETM Platform.
Soteria Biotherapeutics headquarter office and corporate office address is located in 953 Indiana Street San Francisco, CA 94107 United States.
Soteria Biotherapeutics was founded in United States.
In 2024, Soteria Biotherapeutics is currently focus on T-LITETM platform sector.
Above is snippet of Google Trends for "T-LITETM platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Soteria Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
